Junsheng Wang, MD, PhD
Exec. Director, Head of Clinical Pharmacology & Early Development

Dr. Wang is a physician scientist and clinical pharmacologist with more than 30+ years career experiences in medical practice, academic research, and pharmaceutical industry drug development. He previously worked in pharmaceutical companies such as Bristol-Myers Squibb, Novartis, Daiichi Sankyo, and Hengrui Therapeutics Inc. prior to joining Hengrui USA.

Dr. Wang obtained his MD degree from XiangYa Medical College in Changsha, Hunan, China. He is a staff physician in XiangYa Hospital and a lecture in the Pharmacogenetic Research Institute of XiangYa Medical College. He obtained his Ph.D. at the Faculty of Medicine, University of Helsinki with major in Medical Sciences and Clinical Pharmacology. Dr. Wang had his postdoctoral training in the Institute of Psychiatry, Medical University of South Carolina, and became a faculty member in the same institution. Dr. Wang was involved in clinical drug development in multidisciplinary research areas including Neuroscience and Oncology. He has authored/coauthored more than 50 peer-reviewed publications in reputable international journals.